Real-time enrollment status for this melanoma clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 2:28 AM UTC
| NCT Number | NCT06246916 |
| Recruiting Status | Recruiting |
| Condition | Melanoma |
| Phase | PHASE3 |
| Target Enrollment | 560 participants |
| Active Locations | 105 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | August 19, 2026 (2 weeks ago) |
As of September 3, 2026: Clinical trial NCT06246916 is currently recruiting participants. This phase3 study for melanoma is actively seeking new participants at 105 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06246916 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 105 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06246916 was last updated 2 weeks ago (August 19, 2026). HelloStudys verifies this status automatically.